These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26033735)

  • 1. TXA709, an FtsZ-Targeting Benzamide Prodrug with Improved Pharmacokinetics and Enhanced In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus.
    Kaul M; Mark L; Zhang Y; Parhi AK; Lyu YL; Pawlak J; Saravolatz S; Saravolatz LD; Weinstein MP; LaVoie EJ; Pilch DS
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4845-55. PubMed ID: 26033735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An FtsZ-targeting prodrug with oral antistaphylococcal efficacy in vivo.
    Kaul M; Mark L; Zhang Y; Parhi AK; Lavoie EJ; Pilch DS
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5860-9. PubMed ID: 24041882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant
    Bryan E; Ferrer-González E; Sagong HY; Fujita J; Mark L; Kaul M; LaVoie EJ; Matsumura H; Pilch DS
    ACS Chem Biol; 2023 Mar; 18(3):629-642. PubMed ID: 36854145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus.
    Kaul M; Mark L; Parhi AK; LaVoie EJ; Pilch DS
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4290-6. PubMed ID: 27161635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and in vivo antistaphylococcal efficacy of TXY541, a 1-methylpiperidine-4-carboxamide prodrug of PC190723.
    Kaul M; Mark L; Zhang Y; Parhi AK; LaVoie EJ; Pilch DS
    Biochem Pharmacol; 2013 Dec; 86(12):1699-707. PubMed ID: 24148278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved small-molecule inhibitor of FtsZ with superior in vitro potency, drug-like properties, and in vivo efficacy.
    Stokes NR; Baker N; Bennett JM; Berry J; Collins I; Czaplewski LG; Logan A; Macdonald R; Macleod L; Peasley H; Mitchell JP; Nayal N; Yadav A; Srivastava A; Haydon DJ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):317-25. PubMed ID: 23114779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
    Tan CM; Therien AG; Lu J; Lee SH; Caron A; Gill CJ; Lebeau-Jacob C; Benton-Perdomo L; Monteiro JM; Pereira PM; Elsen NL; Wu J; Deschamps K; Petcu M; Wong S; Daigneault E; Kramer S; Liang L; Maxwell E; Claveau D; Vaillancourt J; Skorey K; Tam J; Wang H; Meredith TC; Sillaots S; Wang-Jarantow L; Ramtohul Y; Langlois E; Landry F; Reid JC; Parthasarathy G; Sharma S; Baryshnikova A; Lumb KJ; Pinho MG; Soisson SM; Roemer T
    Sci Transl Med; 2012 Mar; 4(126):126ra35. PubMed ID: 22440737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Lactam Antibiotics with a High Affinity for PBP2 Act Synergistically with the FtsZ-Targeting Agent TXA707 against Methicillin-Resistant Staphylococcus aureus.
    Ferrer-González E; Kaul M; Parhi AK; LaVoie EJ; Pilch DS
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inhibitor of FtsZ with potent and selective anti-staphylococcal activity.
    Haydon DJ; Stokes NR; Ure R; Galbraith G; Bennett JM; Brown DR; Baker PJ; Barynin VV; Rice DW; Sedelnikova SE; Heal JR; Sheridan JM; Aiwale ST; Chauhan PK; Srivastava A; Taneja A; Collins I; Errington J; Czaplewski LG
    Science; 2008 Sep; 321(5896):1673-5. PubMed ID: 18801997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of RND-type efflux pumps confers the FtsZ-directed prodrug TXY436 with activity against Gram-negative bacteria.
    Kaul M; Zhang Y; Parhi AK; Lavoie EJ; Pilch DS
    Biochem Pharmacol; 2014 Jun; 89(3):321-8. PubMed ID: 24637241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus.
    Song D; Bi F; Zhang N; Qin Y; Liu X; Teng Y; Ma S
    Bioorg Med Chem; 2020 Nov; 28(21):115729. PubMed ID: 33065440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.
    Luther MK; LaPlante KL
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7790-4. PubMed ID: 26369963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
    Rio-Marques L; Hartke A; Bizzini A
    Microb Drug Resist; 2014 Dec; 20(6):539-43. PubMed ID: 25010140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo.
    Ni S; Wei H; Li B; Chen F; Liu Y; Chen W; Xu Y; Qiu X; Li X; Lu Y; Liu W; Hu L; Lin D; Wang M; Zheng X; Mao F; Zhu J; Lan L; Li J
    J Med Chem; 2017 Oct; 60(19):8145-8159. PubMed ID: 28880552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
    Barber KE; Smith JR; Ireland CE; Boles BR; Rose WE; Rybak MJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination with a FtsZ inhibitor potentiates the in vivo efficacy of oxacillin against methicillin-resistant
    Kaul M; Ferrer-González E; Mark L; Parhi AK; LaVoie EJ; Pilch DS
    Med Chem Res; 2022 Oct; 31(10):1705-1715. PubMed ID: 37065467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.
    Patel MV; De Souza NJ; Gupte SV; Jafri MA; Bhagwat SS; Chugh Y; Khorakiwala HF; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4754-61. PubMed ID: 15561853
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Barman TK; Kumar M; Mathur T; Namba E; Singh D; Chaira T; Kurosaka Y; Yamada M; Upadhyay DJ; Masuda N
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
    Leonard SN; Rybak MJ
    J Antimicrob Chemother; 2009 Jan; 63(1):155-60. PubMed ID: 18984644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.